(Total Views: 861)
Posted On: 08/22/2020 11:40:55 PM
Post# of 153981
Found this posted on the Yahoo board by a member named Josh.
Looks like we have a new member of the Management Team.
Impressive pedigree and a vote of confidence for the cancer indications.
Scroll to the bottom of this page:
https://www.cytodyn.com/our-people/management-team
His Linkedin page seems to suggest that he started in July, but the website appears to have only been updated recently.
https://www.linkedin.com/authwall?trk=ripf&am...an-brothen
Looks like we have a new member of the Management Team.
Impressive pedigree and a vote of confidence for the cancer indications.
Scroll to the bottom of this page:
https://www.cytodyn.com/our-people/management-team
Quote:
Brian Brothen
Vice President of Global Oncology
Brian Brothen brings to CytoDyn over two decades of commercial pharmaceutical, diagnostic, and medical device oncology experience. He has excelled in sales, commercial leadership, business development, strategic planning, and key opinion leader development. Prior to joining CytoDyn, Mr. Brothen was the Vice President of Sales and Business Development for QT Ultrasound and Paradigm Dx, where he led the launch of the company’s new NGS cancer diagnostic test to help deliver personalized cancer therapy. Mr. Brothen has held numerous oncology sales and sales leadership positions at Agendia, Pharmion (Celgene), Sanofi, and Schering Plough. Mr. Brothen graduated from the University of South Florida with a degree in Business and Communications.
His Linkedin page seems to suggest that he started in July, but the website appears to have only been updated recently.
https://www.linkedin.com/authwall?trk=ripf&am...an-brothen
(4)
(0)
